Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Toffoli

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Pharmacology & Therapeutics|April 20, 2023
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenuesElisa Menozzi, Marco Toffoli, Anthony H V Schapira
Journal of Neurochemistry|January 23, 2020
The biochemical basis of interactions between Glucocerebrosidase and alpha-synuclein in GBA1 mutation carriersMarco Toffoli, Laura Smith, Anthony H V Schapira
Movement Disorders : Official Journal of the Movement Disorder Society|September 22, 2023
Sex Distribution of GBA1 Variants Carriers with Dementia with Lewy Bodies and Parkinson's DiseaseMarco Toffoli, Anthony H V Schapira, Christos Proukakis
Communications Biology|May 9, 2025
Reply to: Is Gauchian genotyping of GBA1 variants reliable?Marco Toffoli, Anthony H V Schapira, Fritz J Sedlazeck, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2020
Biofluid Biomarkers in Parkinson's Disease: Clarity Amid ControversySophia R L Vieira, Marco Toffoli, Philip Campbell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2026
Ambroxol for Parkinson's DiseaseMarco Toffoli, Elisa Menozzi, Kashfia Chowdhury, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2019
Evolution of prodromal parkinsonian features in a cohort of <i>GBA</i> mutation-positive individuals: a 6-year longitudinal studyMicol Avenali, Marco Toffoli, Stephen Mullin, et al.
Neurodegenerative Disease Management|October 20, 2021
The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher diseaseAbigail Louise Higgins, Marco Toffoli, Stephen Mullin, et al.
Annals of Medicine|August 12, 2025
Mitochondrial function is impaired in long COVID patientsJane Macnaughtan, Kai-Yin Chau, Ewen Brennan, et al.
Nature Communications|January 6, 2026
VACmap: an accurate long-read aligner for unraveling complex genomic rearrangementsHongyu Ding, Fritz J Sedlazeck, Christos Proukakis, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pharmacology & Therapeutics|April 20, 2023
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenuesElisa Menozzi, Marco Toffoli, Anthony H V Schapira
Journal of Neurochemistry|January 23, 2020
The biochemical basis of interactions between Glucocerebrosidase and alpha-synuclein in GBA1 mutation carriersMarco Toffoli, Laura Smith, Anthony H V Schapira
Movement Disorders : Official Journal of the Movement Disorder Society|September 22, 2023
Sex Distribution of GBA1 Variants Carriers with Dementia with Lewy Bodies and Parkinson's DiseaseMarco Toffoli, Anthony H V Schapira, Christos Proukakis
Communications Biology|May 9, 2025
Reply to: Is Gauchian genotyping of GBA1 variants reliable?Marco Toffoli, Anthony H V Schapira, Fritz J Sedlazeck, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2020
Biofluid Biomarkers in Parkinson's Disease: Clarity Amid ControversySophia R L Vieira, Marco Toffoli, Philip Campbell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2026
Ambroxol for Parkinson's DiseaseMarco Toffoli, Elisa Menozzi, Kashfia Chowdhury, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2019
Evolution of prodromal parkinsonian features in a cohort of <i>GBA</i> mutation-positive individuals: a 6-year longitudinal studyMicol Avenali, Marco Toffoli, Stephen Mullin, et al.
Neurodegenerative Disease Management|October 20, 2021
The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher diseaseAbigail Louise Higgins, Marco Toffoli, Stephen Mullin, et al.
Annals of Medicine|August 12, 2025
Mitochondrial function is impaired in long COVID patientsJane Macnaughtan, Kai-Yin Chau, Ewen Brennan, et al.
Nature Communications|January 6, 2026
VACmap: an accurate long-read aligner for unraveling complex genomic rearrangementsHongyu Ding, Fritz J Sedlazeck, Christos Proukakis, et al.
Pageof 3